BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16793320)

  • 1. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment.
    Lin IS; Wu RM; Lee-Chen GJ; Shan DE; Gwinn-Hardy K
    Parkinsonism Relat Disord; 2007 May; 13(4):246-9. PubMed ID: 16793320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinocerebellar Ataxia Type 17 (SCA17).
    Toyoshima Y; Takahashi H
    Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease-like and ataxia syndromes: identification of a family with a de novo SCA17/TBP mutation.
    Bech S; Petersen T; Nørremølle A; Gjedde A; Ehlers L; Eiberg H; Hjermind LE; Hasholt L; Lundorf E; Nielsen JE
    Parkinsonism Relat Disord; 2010 Jan; 16(1):12-5. PubMed ID: 19595623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
    Mariotti C; Alpini D; Fancellu R; Soliveri P; Grisoli M; Ravaglia S; Lovati C; Fetoni V; Giaccone G; Castucci A; Taroni F; Gellera C; Di Donato S
    J Neurol; 2007 Nov; 254(11):1538-46. PubMed ID: 17934876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
    Zühlke C; Dalski A; Schwinger E; Finckh U
    BMC Med Genet; 2005 Jul; 6():27. PubMed ID: 15989694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers.
    Kelp A; Koeppen AH; Petrasch-Parwez E; Calaminus C; Bauer C; Portal E; Yu-Taeger L; Pichler B; Bauer P; Riess O; Nguyen HP
    J Neurosci; 2013 May; 33(21):9068-81. PubMed ID: 23699518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advance in research on spinocerebellar ataxia 17].
    Zhang J; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).
    Rolfs A; Koeppen AH; Bauer I; Bauer P; Buhlmann S; Topka H; Schöls L; Riess O
    Ann Neurol; 2003 Sep; 54(3):367-75. PubMed ID: 12953269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex families with multiple system atrophy.
    Hara K; Momose Y; Tokiguchi S; Shimohata M; Terajima K; Onodera O; Kakita A; Yamada M; Takahashi H; Hirasawa M; Mizuno Y; Ogata K; Goto J; Kanazawa I; Nishizawa M; Tsuji S
    Arch Neurol; 2007 Apr; 64(4):545-51. PubMed ID: 17420317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging.
    Loy CT; Sweeney MG; Davis MB; Wills AJ; Sawle GV; Lees AJ; Tabrizi SJ
    Mov Disord; 2005 Nov; 20(11):1521-3. PubMed ID: 16037935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
    Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
    J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-expanded allele spinocerebellar ataxia 17: imaging and phenotypic variability.
    Paolini Paoletti F; Prontera P; Nigro P; Simoni S; Cappelletti G; Filidei M; Calabresi P; Parnetti L; Tambasco N
    Neurol Sci; 2021 Oct; 42(10):4309-4315. PubMed ID: 34031796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein].
    Nakamura K
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal dystonia as a presenting sign of spinocerebellar ataxia 17.
    Hagenah JM; Zühlke C; Hellenbroich Y; Heide W; Klein C
    Mov Disord; 2004 Feb; 19(2):217-20. PubMed ID: 14978680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex Ataxia-Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia.
    Nanetti L; Magri S; Fichera M; Castaldo A; Nigri A; Pinardi C; Mongelli A; Sarro L; Pareyson D; Grisoli M; Gellera C; Di Bella D; Mariotti C; Taroni F
    Mov Disord; 2023 Apr; 38(4):665-675. PubMed ID: 36799493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of Stridor During Sleep in a Patient With Spinocerebellar Ataxia Type 17.
    Kim KJ; Kim JM; Bae YJ; Yoon IY; Song YS; Kim SE
    J Clin Sleep Med; 2019 Jan; 15(1):153-155. PubMed ID: 30621838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG-PET presentation in spinocerebellar ataxia 17: a case report.
    Grassini A; Cermelli A; Roveta F; Zotta M; Lesca A; Marcinnò A; Ferrandes F; Piella E; Boschi S; Lombardo C; Brusco A; Gallone S; Rubino E; Bruni A; Rainero I
    Neurol Sci; 2024 Jun; 45(6):2877-2880. PubMed ID: 38494459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TATA-binding protein in neurodegenerative disease.
    van Roon-Mom WM; Reid SJ; Faull RL; Snell RG
    Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe and rapidly progressing cognitive phenotype in a SCA17-family with only marginally expanded CAG/CAA repeats in the TATA-box binding protein gene: a case report.
    Nielsen TT; Mardosiene S; Løkkegaard A; Stokholm J; Ehrenfels S; Bech S; Friberg L; Nielsen JK; Nielsen JE
    BMC Neurol; 2012 Aug; 12():73. PubMed ID: 22889412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.